Paris, France and Trieste, Italy – June 11, 2024 – 6:30 p.m. CEST – Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers thanks to a unique and fully automated solution for medical laboratories. medical analyses, and Ulisse Biomed Spa (“UBM”) are pleased to announce a strategic collaboration aimed at strengthening their technical and commercial capabilities in the field of cancer diagnostics.
UBM is a biotechnology company specializing in the healthcare sector, particularly in the areas of diagnostics, theranostics and therapeutics, capable of generating innovative and competitive products in these areas thanks to its three proprietary technology platforms.